Gornitzky represented the underwriters, led by Piper Jaffray, in Vascular Biogenics Ltd.’s (operating as VBL Therapeutics) USD 15 million offering of shares and warrants on the NASDAQ Global Market. VBL Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class treatments for cancer.
Piper Jaffray & Co. acted as sole bookrunner for the offering. JMP Securities acted as lead manager and Roth Capital Partners and LifeSci Capital acted as co-managers.
The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.